Claris Lifesciences Ltd |
---|
Registered Office: Claris Corporate Headquarters, Ellisbridge, Ahmedabad - 380006, Gujarat |
Phone: 91-79-26563331/66309339 |
Email: investorservices.corp@clarislifesciences.com |
Website: www.clarislifesciences.com |
Public issue of 12,632,477 equity share of face value of Rs. 10 each (The "Equity Shares") of Claris Lifesciences Limited (The "Company" or The "Issuer") for cash at a price of Rs. 228 per equity share (including a Share Premium of Rs. 218) to all investors other than Anchor Investors and at a Price of Rs. 293 (including a Share Premium of Rs. 283) per equity share to Anchor Investors amounting to Rs 246.00 crore in relation to all investors other than anchor investors and amounting to Rs. 54.00 crore in relation to Anchor investors aggregating upto Rs. 300.00 crore (The "Issue"). The issue will constitute 19.79% of the Post-issue Paid-Up Share Capital of the Company. Issue price: Rs. 228 per equity share of face value Rs. 10 each The issue price is 22.8 times of the face value |
Issue | Money Payable On | ||
---|---|---|---|
Opens On | Closes On | Application | Allotment |
24-Nov-2010 | 02-Dec-2010 | ₹ 228.00 | ₹ 0.00 |
Minimum Application for shares in Nos : 22.0 Further Multiples of : 22.0 | ||
---|---|---|
(₹)Cr. | Lead Managers to the Issue | |
Project Cost | 274.26 | Edelweiss Capital Ltd |
Project Financed through Current Offer | 300.00 | |
Post Issue Equity Share Capital | 63.82 | |
Issue Price | ₹228.00 |
Projects |
---|
Setting up of a new plant compri. a PVC bag line |
Setting up of a new manu. line for propofol |
Construction of a facility for R & D |
Prepayment of an identified term loan |
General corporate purposes |
Promoted By |
---|
Arjun S Handa |
Sarjan Financial Pvt Ltd |
Listing At |
---|
BSE |
Registrar to the Issue |
---|